Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Oct 26;5(10):999-1001.
doi: 10.1016/j.jacbts.2020.09.002. eCollection 2020 Oct.

Cerclage Septal Ablation for Hypertrophic Cardiomyopathy: Will a Backdoor Attack on the Septum Be Better?

Richard G Bach  1
Affiliations
Editorial

Cerclage Septal Ablation for Hypertrophic Cardiomyopathy: Will a Backdoor Attack on the Septum Be Better?

Richard G Bach. JACC Basic Transl Sci. .
No abstract available

Keywords: hypertrophic cardiomyopathy; radiofrequency ablation; septal ablation; septal reduction therapy.

PubMed Disclaimer

Conflict of interest statement

Dr. Bach has received institutional research funding for Washington University School of Medicine, but no personal compensation, from MyoKardia and Cytokinetics.

Figures

None
Graphical abstract
See this image and copyright information in PMC

Comment on

References

    1. Morrow A.G., Brockenbrough E.C. Surgical treatment of idiopathic hypertrophic subaortic stenosis - technic and hemodynamic results of subaortic ventriculomyotomy. Ann Surg. 1961;154:181–189. - PMC - PubMed
    1. Sigwart U. Nonsurgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995;346:211–214. - PubMed
    1. Nagueh S.F., Groves B.M., Schwartz L. Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy a multicenter North American Registry. J Am Coll Cardiol. 2011;58:2322–2328. - PubMed
    1. Yang H.N., Yang Y., Xue Y.H., Luo S.X. Efficacy and safety of radiofrequency ablation for hypertrophic obstructive cardiomyopathy: a systematic review and meta-analysis. Clin Cardiol. 2020;43:450–458. - PMC - PubMed
    1. Shin E.-S., Chon M.-K., Jun E.J. Septal reduction using transvenous intramyocardial cerclage radiofrequency ablation: preclinical feasibility. J Am Coll Cardiol Basic Trans Science. 2020;5:988–998. - PMC - PubMed

LinkOut - more resources